GeneType Multi-Test Receives Regulatory Approval for Commercial Release in USA and Australia
22. Februar 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
Genetic Technologies Reports Q2 FY22 Cash Flow Results
19. Januar 2022 09:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, ‘Company’, ‘GENE’, ‘geneType’), a diversified Genomics and AI driven preventative health...
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, ‘Company’, ‘GENE’, ‘geneType’), a global leader in genomics-based tests in health, wellness and serious disease provides the following business update:
21. Dezember 2021 08:00 ET
|
Genetic Technologies Ltd
Forecast 2QFY221 cash receipts +112% versus the prior quarter (1QFY22) to A$1.8 million following the completed integration of EasyDNA in the quarterMulti-Test technical validation complete and...
GENE Presents Study Involving 200,000 Participants at 2021 San Antonio Breast Cancer Symposium
10. Dezember 2021 07:30 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Dec. 10, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
Genetic Technologies Announces New Partnership and geneType COVID-19 Risk Test Patent Allowance from the USPTO
09. Dezember 2021 07:30 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
Genetic Technologies Reports Q1 FY22 Results
25. Oktober 2021 08:30 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in Genomics based tests in health, wellness and...
GENE Delivers Material 12-Fold Increase in Revenue in the Quarter Ended September 2021
04. Oktober 2021 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
Genetic Technologies Limited Interview to Air on Bloomberg TV (U.S.) on the RedChip Money Report®
30. September 2021 09:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in Genomics based tests in health, wellness and...
GENE Embarks on Breakthrough African American Collaboration for Breast Cancer as Part of Its Commitment to Ethnic Diversity
28. September 2021 08:04 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics and AI driven preventative health business...
Genetic Technologies Reports FY21 Results as it Turns the Corner on its Commercialization Strategy
31. August 2021 09:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in Genomics based tests in health, wellness and...